A detailed history of Stifel Financial Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 100,593 shares of CRL stock, worth $18.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
100,593
Previous 110,918 9.31%
Holding current value
$18.7 Million
Previous $22.9 Million 13.52%
% of portfolio
0.02%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$187.96 - $245.29 $1.94 Million - $2.53 Million
-10,325 Reduced 9.31%
100,593 $19.8 Million
Q2 2024

Aug 13, 2024

BUY
$206.39 - $268.73 $283,167 - $368,697
1,372 Added 1.25%
110,918 $22.9 Million
Q1 2024

May 13, 2024

BUY
$203.52 - $273.43 $809,602 - $1.09 Million
3,978 Added 3.77%
109,546 $29.7 Million
Q4 2023

Feb 12, 2024

SELL
$164.52 - $238.84 $86,702 - $125,868
-527 Reduced 0.5%
105,568 $25 Million
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $342,408 - $383,211
1,761 Added 1.69%
106,095 $20.8 Million
Q2 2023

Aug 14, 2023

BUY
$183.71 - $210.25 $1.23 Million - $1.41 Million
6,704 Added 6.87%
104,334 $21.9 Million
Q1 2023

May 12, 2023

BUY
$191.89 - $259.92 $537,675 - $728,295
2,802 Added 2.95%
97,630 $19.7 Million
Q4 2022

Feb 13, 2023

SELL
$197.11 - $250.07 $1.01 Million - $1.28 Million
-5,137 Reduced 5.14%
94,828 $20.7 Million
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $537,285 - $737,840
2,945 Added 3.04%
99,965 $19.7 Million
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $389,888 - $577,584
1,910 Added 2.01%
97,020 $20.8 Million
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $1.37 Million - $1.95 Million
5,375 Added 5.99%
95,110 $27 Million
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $1.34 Million - $1.71 Million
3,804 Added 4.43%
89,735 $33.8 Million
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $661,808 - $813,940
1,776 Added 2.11%
85,931 $35.5 Million
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $3.55 Million - $4.49 Million
12,079 Added 16.76%
84,155 $31.1 Million
Q1 2021

May 14, 2021

BUY
$249.67 - $299.48 $1.01 Million - $1.22 Million
4,058 Added 5.97%
72,076 $20.9 Million
Q4 2020

Feb 12, 2021

BUY
$222.0 - $252.62 $1.52 Million - $1.73 Million
6,838 Added 11.18%
68,018 $17 Million
Q3 2020

Nov 16, 2020

BUY
$175.56 - $226.45 $863,404 - $1.11 Million
4,918 Added 8.74%
61,180 $13.9 Million
Q2 2020

Aug 14, 2020

BUY
$118.84 - $189.72 $607,866 - $970,417
5,115 Added 10.0%
56,262 $9.81 Million
Q1 2020

May 14, 2020

BUY
$98.9 - $178.34 $403,907 - $728,340
4,084 Added 8.68%
51,147 $6.44 Million
Q4 2019

Feb 13, 2020

BUY
$126.05 - $152.76 $371,847 - $450,642
2,950 Added 6.69%
47,063 $7.19 Million
Q3 2019

Nov 19, 2019

SELL
$125.07 - $143.67 $14,508 - $16,665
-116 Reduced 0.26%
44,113 $5.85 Million
Q3 2019

Nov 13, 2019

BUY
$125.07 - $143.67 $849,975 - $976,381
6,796 Added 18.16%
44,229 $5.86 Million
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $1.47 Million - $1.78 Million
11,952 Added 46.91%
37,433 $5.32 Million
Q1 2019

May 14, 2019

BUY
$104.82 - $146.73 $162,051 - $226,844
1,546 Added 6.46%
25,481 $3.69 Million
Q4 2018

Feb 13, 2019

BUY
$105.09 - $137.23 $138,298 - $180,594
1,316 Added 5.82%
23,935 $2.7 Million
Q3 2018

Nov 13, 2018

BUY
$112.11 - $134.54 $2.54 Million - $3.04 Million
22,619 New
22,619 $3.04 Million
Q1 2018

May 11, 2018

SELL
$98.19 - $115.2 $204,824 - $240,307
-2,086 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$100.43 - $118.09 $9,741 - $11,454
-97 Reduced 4.44%
2,086 $226,000
Q3 2017

Nov 13, 2017

BUY
$96.72 - $109.26 $211,139 - $238,514
2,183
2,183 $0

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.